Shivinder Singh is a young entrepreneur who aims to change the way health care is delivered in the world. He is the Managing Director of Fortis Healthcare (India) Limited. He is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited, Fortis Clinical Research Limited and serves as a Director on the Board of Religare Technologies Limited. Singh was one of the key promoters of Ranbaxy Laboratories and served as Director on the Board of the pharma major. He played a strategic role in the sale of Ranbaxy, thereby taking the company to the next level and creating significant long-term value for all stakeholders.
An alumnus of Doon School and an honors graduate in mathematics from St. Stephens College, Delhi, Singh earned an MBA with specialization in Health Sector Management from Duke University’s Fuqua School of Business, where he is also a member of the Board of Visitors.
Singh’s strategy for Fortis and its execution has been recognized by Harvard Business School in the form of a case study. Singh has played an important and active role in shaping the private health care space in India as the Chairperson of Health Services Committee of Federation of Indian Chambers of Commerce and Industry (FICCI). Presently, he is the Chairperson of FICCI Young Leaders and board member of Indo British Partnership Network (IBPN), former Board Member of National Accreditation Board for Hospital and Healthcare Providers (NABH) and chair of the health care committee of UKTI (UK Trade & Investment). He is also on the National Board of Advisors of AIESEC, a global, non-political, independent, not-for-profit organization run by students and recent graduates of institutions of higher education. Singh is a fellow of Aspens India Leadership Initiative and a director of Step by Step school.